REGENERON PHARMACEUTICALS, INC. Total Liabilities 2009-2026 | REGN
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is REGENERON PHARMACEUTICALS, INC.'s current total liabilities?
REGENERON PHARMACEUTICALS, INC. (REGN) annual total liabilities for 2025 was $9.30B, a 10.66% increase from 2024. REGENERON PHARMACEUTICALS, INC. total liabilities for the quarter ending March 31, 2026 was $9.45B.
What was REGENERON PHARMACEUTICALS, INC.'s total liabilities in 2024?
REGENERON PHARMACEUTICALS, INC. annual total liabilities for 2024 was $8.41B, a 18.27% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s total liabilities in 2023?
REGENERON PHARMACEUTICALS, INC. annual total liabilities for 2023 was $7.11B, a 8.50% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year total liabilities CAGR?
REGENERON PHARMACEUTICALS, INC. total liabilities grew at a compound annual growth rate (CAGR) of 8.67% from FY2020 to FY2025, going from $6.14B to $9.30B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.30B | +10.7% | 10-K |
| FY2024 | $8.41B | +18.3% | 10-K |
| FY2023 | $7.11B | +8.5% | 10-K |
| FY2022 | $6.55B | -1.7% | 10-K |
| FY2021 | $6.67B | +8.6% | 10-K |
| FY2020 | $6.14B | +65.2% | 10-K |
| FY2019 | $3.72B | +24.8% | 10-K |
| FY2018 | $2.98B | +13.6% | 10-K |
| FY2017 | $2.62B | +3.8% | 10-K |
| FY2016 | $2.52B | +29.2% | 10-K |
| FY2015 | $1.95B | +51.8% | 10-K |
| FY2014 | $1.29B | +28.9% | 10-K |
| FY2013 | $998.9M | +19.6% | 10-K |
| FY2012 | $835.1M | -0.3% | 10-K |
| FY2011 | $837.9M | +49.2% | 10-K |
| FY2010 | $561.6M | +63.1% | 10-K |
| FY2009 | $344.4M | - | 10-K |